The Market Statsville Group (MSG) publishes the new report on the "Aerosol Delivery Devices Market by Component (Solution, Service), by Waste Type (Solid Waste, Special Waste, E-Waste), by Smart Method (Collection, Processing, Disposal, Energy Recovery), by Application (Residential, Commercial, Industrial), by Region – Global Share and Forecast to 2027". By 2027, the global aerosol delivery devices market size is projected to grow USD 20,918.7 million from USD 14,392.4 million in 2020, registering a CAGR of 4.9% during the forecast period.  Aerosol delivery devices allow selective treatment for respiratory diseases, owing to their advantages of achieving high drug concentrations in airways, coupled with reduced systemic side effects by manually controlling systemic drug levels. Portable ?2-agonists (bronchodilators) offer rapid onset of action compared to oral delivery medications. Some drugs are only active with aerosol drug delivery. Aerosol drug delivery mechanism is a cost-effective and painless delivery option. However, training is required for specific inhalation techniques for proper use of various types of portable inhaler devices, as a less-than-optimal technology may result in reduced drug delivery.

Request Sample Copy of this Report: 

Global Aerosol Delivery Devices Market Segmentation

The overall aerosol delivery devices market has been segmented into the product, distribution channel, application, and region.

By Product Outlook (Revenue, USD Million, 2017-2027)

Dry powder inhalersSingle-dose inhalersMulti-dose inhalersMetered-dose inhalersConventional pressurized inhalers,Soft mist inhalersNebulizersJet nebulizersUltrasonic wave nebulizersVibrating mesh nebulizers

By Distribution Channel Outlook (Revenue, USD Million, 2017-2027)

Retail pharmaciesHospital pharmaciesE-commerce

By Application Outlook (Revenue, USD Million, 2017-2027)

AsthmaChronic obstructive pulmonary diseaseCystic fibrosisNon-respiratory diseasesDiabetesAnalgesiaParkinson’s disease

Direct Purchase Report: 

By Region Outlook (Revenue, USD Million, 2017-2027)

North America (US, Canada, Mexico)South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA)

Retail pharmacies, by distribution channel, is estimated to hold the largest market share during the forecast period

On the basis of distribution channels, the global aerosol delivery devices market is categorized into retail pharmacies, hospital pharmacies, and e-commerce. The retail pharmacies segment accounted for the largest revenue in 2020 and is anticipated to grow at a CAGR of 4.1% during the forecast period, owing to their convenient offers and the strong presence of retail pharmacies across the globe. However, the e-commerce segment is anticipated to grow significantly in the future, owing to an increase in preference for online purchasing of aerosol delivery devices over traditional methods.

A retail pharmacy is a business, which involves the selling of cosmetics, first-aid supplies, prescription medications, and nonprescription medications or over-the-counter products. The population prefers retail pharmacies as it is the oldest and most conventional medium distributing aerosol delivery devices to consumers, owing to its extensive distribution network. Further, pharmacists play a relevant role in patient education & counseling, drug safety management, medication review, monitoring and reconciliation, detection, and control of specific respiratory risk factors by providing them with general health information. Thus, these factors offer significant opportunities for the aerosol delivery devices market during the forecast period.

Access full Report Description, TOC, Table of Figure, Chart, etc: 

North America accounts for the largest market share in aerosol delivery devices market 2020

Based on the regions, the global aerosol delivery devices market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. North America accounted for a major share in the aerosol delivery devices market in 2020 and is predictable to maintain its dominance during the forecast period, owing to the increased number of asthma and COPD patients, surge in demand for aerosol delivery devices, availability of advanced healthcare facilities with trained medical professionals, rise in the number of R&D activities, coupled with a large presence of key players, and surge in investments made by governments in the healthcare system.

The presence of major players in the region includes 3M Company, AeroGen, Inc., Johnson & Johnson (Actelion Pharmaceuticals Ltd), ResMed Corporation (Propeller Health), and Merck & Co., Inc. drives the growth of the aerosol delivery devices market in North America. In addition, the rise in pollution and smokers is the primary factor for the increase in the prevalence of asthma and COPD, which significantly contributes toward the growth of the market. For instance, according to the Centers for Disease Control and Prevention, in 2018, nearly 14 of every 100 U.S. adults aged 18 years or older smoked cigarettes. Moreover, according to the CDC, in 2018, almost 25 million people in the U.S. had asthma, and16 million people were suffering from COPD. Furthermore, the presence of a large aged population, ease of availability of aerosol delivery devices, favorable reimbursement policies, and higher healthcare awareness among the general population toward their use propel the market growth.

Browse complete report:

Major players operating in the global market of aerosol delivery devices are 3M Company, Aerogen, INC, Merck & co., INC., Metall Zug Group, GlaxoSmithKline Plc (GSK),  Koninklijke Philips N.V., Recipharm AB (Bespak), Johnson & Johnson (Actelion Pharmaceuticals Ltd), Teva Pharmaceutical Industries Limited, Vectura Group PLC, Heitkamp & Thumann KG (H&T Presspart), Iconovo AB, Gerresheimer AG, Merxin LTD, and Nemera.

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

Contact US:

Eric Martin
800 Third Avenue Suite A #1519
New York, NY 10022
+1 (646) 663-5829 | India: +91-702-496-8807
Email: [email protected]
LinkedIn | Facebook | Twitter